GLYX-13

DRUG3 trials

Sponsors

Naurex, Inc, an affiliate of Allergan plc, Northwestern University

Conditions

HealthyMajor Depressive DisorderPsychiatric Illness

Phase 1

Single Ascending Dose Safety, Tolerability and Pharmacokinetics Study of GLYX-13 in Normal Volunteers

CompletedNCT01014650

Naurex, Inc, an affiliate of Allergan plcHealthy

Start: 2009-11-30End: 2015-10-31Updated: 2016-02-22

Phase 2

Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression

CompletedNCT01234558

Naurex, Inc, an affiliate of Allergan plcMajor Depressive Disorder

Start: 2011-05-31End: 2012-07-31Updated: 2012-09-12

Effects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric Illness

TerminatedNCT01844726

Northwestern UniversityHealthy, Psychiatric Illness

Start: 2013-05-31End: 2016-01-31Updated: 2023-04-20